Product NDC: | 0310-0720 |
Proprietary Name: | FASLODEX |
Non Proprietary Name: | Fulvestrant |
Active Ingredient(s): | 50 mg/mL & nbsp; Fulvestrant |
Administration Route(s): | INTRAMUSCULAR |
Dosage Form(s): | INJECTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0310-0720 |
Labeler Name: | AstraZeneca Pharmaceuticals LP |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA021344 |
Marketing Category: | NDA |
Start Marketing Date: | 20101101 |
Package NDC: | 0310-0720-10 |
Package Description: | 2 SYRINGE, GLASS in 1 CARTON (0310-0720-10) > 5 mL in 1 SYRINGE, GLASS |
NDC Code | 0310-0720-10 |
Proprietary Name | FASLODEX |
Package Description | 2 SYRINGE, GLASS in 1 CARTON (0310-0720-10) > 5 mL in 1 SYRINGE, GLASS |
Product NDC | 0310-0720 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Fulvestrant |
Dosage Form Name | INJECTION |
Route Name | INTRAMUSCULAR |
Start Marketing Date | 20101101 |
Marketing Category Name | NDA |
Labeler Name | AstraZeneca Pharmaceuticals LP |
Substance Name | FULVESTRANT |
Strength Number | 50 |
Strength Unit | mg/mL |
Pharmaceutical Classes | Estrogen Receptor Antagonist [EPC],Estrogen Receptor Antagonists [MoA],Selective Estrogen Receptor Modulators [MoA] |